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The apparent suppression of plasma renin activity in essential
hypertensive patients compared to normotensive controls
prompted an examination of factors which might be responsible for
this difference in people taken from a blood pressure screening
survey. Plasma renin activity was lower in 89 previously untreated
"hypertensive" subjects than in an equal number of age- and sex-
matched "controls" from the same community. The rise in plasma
renin activity on standing or after frusemide was proportional to
the resting level, and it was generally less m hypertensives, but
small or absent responses were also seen in those with normal
blood pressure. There was no evidence for a "low renin sub-
group" among the hypertensives. Plasma renin activity fell with
both increasing age and increasing arterial pressure. A low renin
activity is more likely to be a consequence of hypertension than to
be associated with its cause.
Diminution de l'activité refine au cours de l'hypertension artér-
ielle: Une ré-évaluation. La suppression apparente de l'activité
refine plasmatique chez les malades atteints d'hypertension essen-
tielle par comparaison avec des témoins a pression artérielle nor-
male a suscité l'étude des facteurs qui peuvent être responsables
de cette difference chez des sujets appartenant a une enquéte sur
l'hypertension artérielle. L'activité rénine plasmatique était plus
faible chez 89 sujets atteints d'hypertension non traitée antérieure-
ment que chez un nombre egal de sujets tCmoins d'âge et de
sexe correspondants, appartenant a la mCme communauté.
L'augmentation de l'activité renine plasmatique en position de-
bout ou après furosémide est proportionnelle au niveau de base,
elle est généralement inférieure chez les sujets atteints
d'hypertension, mais des reponses nulles ou faibles ont aussi été
observées chez des sujets ayant une pression artérielle normale. Ii
n'y a pas eu de preuve de l'existence d'un sous-groupe "a activité
rénine basse" parmi les malades atteints d'hypertension artérielle.
L'activité rénine plasmatique diminue a la fois en fonction de l'áge
et de l'augmentation de la pression artCrielle. Une activité rénine
faible est plus probablement une consequence de l'hypertension
qu'un fait associé a sa cause.
A substantial proportion of patients with benign
essential hypertension show a reduction in plasma
renin activity (PRA), whether this is measured at rest
or in response to stimuli such as standing, sodium
depletion, or diuretic treatment [1—4]. Renin activity
tends to decrease with age in hypertensive patients,
but whether it does so or not in the normotensive
population is controversial [5—111. There is also evi-
dence of an inverse relationship between plasma
renin and arterial pressure [5, 9, 12—151. Thus, when
plasma renin activity is low in a hypertensive sub-
ject, the possible effects of age, blood pressure, and,
perhaps, the duration of hypertension ought to be
taken into account before other causes of low renin
activity are postulated. Theoretical mechanisms by
which raised arterial pressures may reduce renin
have been put forward [16—181. Earlier suggestions
that renin may be "suppressed" by over-secretion of
an unknown mineralocorticoid do not now find gen-
eral acceptance, although some investigators con-
tinue to support the hypothesis [191. Many factors
affect renin release, and interpretation of published
data has been complicated by the possible effects of
previous drug treatment on renin responses, by the
lack of suitable control data, and by the use of
differing methods for renin assay [201.
In this paper, the effects on plasma renin activity
of two different stimuli to renin release, standing and
frusemide, have been carefully assessed in relation
to data from an equal number of hypertensive pa-
tients and of age- and sex-matched controls drawn
from the same community.
Methods
Subjects with raised arterial pressure were sought
from among the staff of the Atomic Energy Research
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Establishment at Harwell and from the populations
of two nearby general practices. Blood pressures
were measured on the first occasion by the random-
zero sphygmomanometer and subsequently by the
London School of Hygiene sphygomomanometer.
Eighty-nine subjects whose diastolic pressures
(phase 5) exceeded 100 mm Hg on each of four
occasions were arbitrarily designated to have hyper-
tension, and each was matched by a control subject,
from the same community, with a diastolic pressure
below 90 mm Hg (Table 1). All subjects were Cauca-
sian. The duration of hypertension was unknown, as
the patients were unaware that their blood pressures
were raised until the time of screening. The blood
pressure measurements used in the analyses were
those taken after the subject had been lying supine
for five minutes, on his fourth visit to the medical
center. None of the 178 subjects had ever received
antihypertensive treatment, and no other drugs were
being taken. Cushings syndrome, pheochromocy-
toma, primary aldosteronism, and coarctation of the
aorta were excluded on clinical and biochemical evi-
dence. Subjects with retinal hemorrhages, cotton-
wool spots or papilloedema, proteinuria, or an ab-
normal rapid-sequence excretory urogram, were ex-
cluded from the study. Also excluded were pregnant
women or those taking any contraceptive pill and
patients who had suffered a stroke or myocardial
infarct. Endogenous creatinine clearances exceeded
75 mi/mm in all 178 subjects. All gave informed
consent to the procedures entailed in this study.
Plasma renin activity was measured by the method
of Sealey and Laragh [21]. Blood samples for renin
activity were taken at 11 00 hr after two hours of
resting supine, at 13 00 hr after two hours of being
erect, and at 14 00 hr one hour after i.v. administra-
tion of frusemide (1 mg/kg of body wt). Urinary
sodium excretion was measured during the 24 hr
immediately preceding the blood sampling. All sub-
jects were investigated as out-patients, and they con-
tinued on their normal home diets (salt intake was
not controlled).
Differences between groups were assessed by Stu-
dent's unpaired t test, and where the distributions
were skewed, the logarithmic values were used. The
Table 1. Characteristics of the people studied
Hypertensives Controls P
Number 89 89
Male:female 71:18 71:18
Age range, yr 30 to 67 30 to 67
mean 52.2 51.8
Systolic BP, mm Hg 161.5 2.1 123.0 1.3 <0.001
Diastolic BP, mm Hg 104.2 0.9 78.0 1.4 <0.001
Table 2. Plasma renin activity (PRA) and renin responsiveness in
essential hypertensive and matched control subjects
Stimuli
PRA, nglmllhr
PHypertensives Controls
Supine 1.29 0.06 1.45 0.09 NS
Erect 2.70 0.20 3.55 0.21 <0.005
After frusemide i.v. 3.87 0.31 6.29 0.40 <0.001
ASEa 1.40 0.18 2.12 0.17 <0.005
AS-L5 2.55 0.28 4.90 0.35 <0.001
AE-L 1.22 0.17 2.74 0.25 <0.001
a AS-E is the change in PRA from supine to erect.b AS-L is the change from supine to post-frusemide.
E-L is the change from erect to post-frusemide.
relations between variables were measured by Pear-
son's correlation and partial correlation tests. Differ-
ences between regression lines were assessed using it
tests. The distributions were assessed by measure-
ment of kurtosis (peakedness) and of skewness. The
results are expressed as the mean value SEM.
Results
In Table 2, plasma renin activities (PRA) in the
hypertensive patients are compared with those of the
control subjects. Average supine values were lower
in the hypertensive group, although not significantly
so (P <0.06). After standing or injection of frusem-
ide, renin activity increased in both groups, but the
response was significantly less in the hypertensive
group (Table 2). Sodium excretion over 24 hr was
similar in the hypertensives (150.79 5.62 mmoles)
and matched controls (157.91 4.99), and in neither
group was there any correlation between plasma
renin activity and 24-hr sodium excretion. The hy-
pertensive subjects were slightly heavier (77.26
1.11 kg) than the control subjects (72.11 1.08 kg).
Figure 1 shows the frequency distributions of renin
activity in the hypertensive and control subjects.
There was no evidence of a bimodal distribution in
either group, whether the samples were taken from
supine, erect, or frusemide-treated subjects. After
logarithmic transformation, to separate the crowded
lower ream values in an attempt to reveal a sub-
population, these distributions were shown statisti-
cally to be not different from a normal distribution.
The rise of renin after either stimulus was related
to the prevailing renin activity (Fig. 2). Poor re-
sponses were not confined to those with the lowest
supine values but occurred throughout the range of
supine PRA, nor were sluggish responses confined to
the hypertensive group (Fig. 2).
An inverse correlation between age and plasma
renin activity was confirmed for both hypertensive
and control subjects (Table 3). Blood pressure and
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Fig. 2. The relationship between supine plasma renin activity (PRA) and renin responsiveness. S-E is the change
in PRA from supine to erect, and S-L is the change in PRA from supine to post-frusemide. Closed circles (S)
represent hypertensive, and open circles (0), control subjects. The continuous (hypertensive, HI) and the dotted(control, C) regression lines illustrate the relationship between S-E response and supine PRA (hypertensive r
= 0.24, P < 0.03; controls r = 0.30, P < 0.004) and between S-L and supine PRA (hypertensives r = 0.27,
P < 0.02; controls r = 0.46, P — 0.001). The difference between the regression lines was not significant.
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Table 3. Correlations of renin and its responsiveness with age and blood pressure
Plasma renin activity Renin responsiveness"
After i.v.
Supine Erect frusemide S-E S-L E-L
Age
—0.35"hypertensives —0.19 _044d —0.48' —0.48"
controls 027b 040d 044d 037d
Systolic BP
—0.26"hypertensives —0.15 —0.23" 0.30' 0.2l"
—0.20controls —0.14 —0.21" —0.23" —0.19
Diastolic BP
hypertensives —0.01 —0.23" —0.30' 0.27" 0.32e —0.24"
—0.24"controls —0.08 —0.15 —0.23" —0.15
a S-E is the change in PRA from supine to erect, AS-L from supine to post-frusemide, and iE-L from erect to post-frusemide.
b p <0.05.
P < 0.01.
d P <0.001.
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Fig. 1. Frequency distributions of plasma renin activity (PRA) in essential hypertensive and matched control
subjects.
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Table 4. Partial correlations of renin and its responsiveness with age and bood pressure
Correlation
to be
Corrected
for the
Plasma renin activity Renin responsiveness'
After iv.
corrected effect of Supine Erect frusemide S-E S-L E-L
Systolic BP Age
hypertensives —0.19 p,49d 0.44' 035d
controls 040d —0.32
Diastolic BP Age
hypertensives —0.20 050d —0.49 —0.3Sf'
controls 043d —0.42' _O.33c
Age Systolic BP
hypertensives —0.14 _023b —0.20 0.29'
controls
—0.06 —0.09
—-0.11 —0.08 —0.10 —0.10
Age Diastolic BP
hypertensives —0.01 0.28c
controls
—0.03 —0.08 —0.17 —0.08 —0.17 —0.19
S-E is the change in PRA from supine to erect, S-L from supine to post-frusemide, and E-L from erect to post-frusemide.
P < 0.05.
P < 0.01.
P < 0.001.
renin activity were also inversely correlated, but
more consistently in hypertensives than in controls
(Table 3). A partial correlation analysis showed age
and blood pressure to exert independent effects on
plasma renin activity in hypertensive patients, but in
control subjects the correlations between renin and
blood pressure were lost when correcting for the
effects of age (Table 4).
Discussion
The investigation of previously untreated hyper-
tensive patients, each age- and sex-matched with a
control subject from the same community, allows the
firm conclusion that renin activity is reduced in pa-
tients with hypertension, independent of the effects
of aging and of previous drug therapy. The patients
in this study had a mild form of hypertension, and,
therefore, the results may not be relevant to individ-
uals with sustained, markedly elevated blood pres-
sure readings. Until now, the known tendency of
blood pressure to increase with age has left open the
possibility that aging might be an important factor in
previously described inverse relationships between
blood pressure and renin activity [5, 9, 12—15]. The
presence of the matched control group in this series
permits a more critical assessment of the relationship
between arterial pressure and renin; when the effects
of age are allowed for the inverse correlation be-
tween blood pressure and renin remains significant in
the hypertensive subjects.
The separation of some hypertensive patients into
a "low renin group" is difficult to make on sound
statistical grounds. Much of the conflicting data in
this field can be accounted for by the lack of a
universally accepted definition of what constitutes
low-renin hypertension. The two criteria most fre-
quently used in defining this condition are the abso-
lute renin levels and the responsiveness to a renin-
elevating stimulus. It has been shown that the distri-
bution of plasma renin [8] and angiotensin II [22]
form part of a continuum with no evidence of bimo-
dality. Any attempt to subdivide these distributions
must be completely arbitrary, and the data available
from this study does not suggest that such a separa-
tion is reasonable. The low-salt diet has become the
"standard" stimulus to renin release [20]. More
rapid, yet reliable, replacement stimuli have been
sought as possible out-patient tests of renin respon-
siveness, and in this regard, frusemide has been
extensively used both orally [23—27] and i.v. [1—3,
28]. The results are conflicting as to the value of
frusemide in "separating" a low-renin subgroup of
essential hypertension. Nevertheless, Kaplan et al
have shown recently that frusemide, given i.v., iden-
tifies the same group of patients whose renin levels
respond poorly to a low-salt diet [29], and we have
confirmed this work by showing excellent correla-
tions between the renin response to i.v. frusemide
and a low-salt diet (to be published). The pattern of
change of renin activity between supine and stimu-
lated measurements is qualitatively similar, even if
quantitatively different, between hypertensives and
controls (Fig. 2). In both groups the degree of rise in
renin activity is dependent on the supine level; the
highest rises are seen in those with the highest supine
levels and vice versa. The essential difference be-
tween the two groups lies in the lesser degree of rise
in the hypertensive group, a characteristic trend
which is found throughout the range of supine values
and not conilned to those with the lowest supine
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levels (Fig. 2). This observation suggests that a ten-
dency for renin responsiveness to be depressed is a
characteristic of many hypertensive patients, but this
tendency is not a feature of any subgroup which can
be statistically separated.
It is important to note that a considerable variation
in renin responses can be observed for subjects
whose arterial pressures are normal as well as for the
hypertensive patients. Physiologic differences must
exist between patients of the same age, sex, and
blood pressure, in some of whom renin rises mark-
edly after stimulation but fails to do so in others.
Whether this is a question of differences in duration
of hypertension or of the distribution and severity of
changes in the renal circulation is not apparent. The
effect of hypertension itself on renin activity pro-
vides at least a partial explanation of lower renin
activity in hypertension without the need to invoke
the presence of excessive secretion of an unknown
mineralocorticoid. Possible mechanisms by which
raised arterial pressure and aging might reduce the
capacity of the kidney to increase plasma renin activ-
ity have been discussed by others [5—10, 16—181.
Their concepts are difficult to prove or disprove, but
this is less important than the need to establish
whether or not "low renin hypertension" is an entity
reflecting a cause of hypertension different from that
of other patients. The evidence of this study and that
of others [2, 30, 31] does not support the possibility
of a separate cause.
Our findings and interpretation of them are not
incompatible with observations that the blood pres-
sure of patients with low renin activity responds
better to diuretic agents [32] while beta-adrenergic
blockade is more effective in those with high renin
activity [33]. Such observations are themselves con-
troversial but, if true, do not necessarily imply that
the etiology of hypertension is different between the
two groups: it may be, rather, that the effects of the
disease on the renal circulation are different.
The failure to find any relation between urine so-
dium excretion and plasma renin activity is in con-
trast to the finding of Brunner et al [34]. In our study,
the salt intake was unrestricted and moderate, as
reflected by 95% of the subjects excreting between
140 and 165 mmoles of sodium in their urines, with
only a single measurement of renin activity vs. uri-
nary sodium representing each subject. In the study
of Brunner et al, observations were made on the
same subjects while taking low- and high-salt intakes
separately, as well as when on a free diet. The
relationships between renin activity and dietary so-
dium intake may differ, depending upon whether
sodium intake has been changed acutely or reflects a
more stable dietary habit. Most of the points relating
the two variables in our study fell in the middle range
of sodium excretion, occupying, therefore, only a
part of the area described by the nomogram of Brun-
ner et al.
It seems likely from the results of this investigation
that a relatively inactive renin-angiotensin system is
part of the natural history of essential hypertension.
No support has been found for a separate specific
entity of "low renin hypertension."
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